| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $393.5M | +8.6% | +70.0% |
| Cost of Revenue | $287.8M | +8.6% | +88.0% |
| Gross Profit | $105.7M | +8.8% | +34.9% |
| R&D Expense | $2.3M | -8.0% | +43.8% |
| SG&A Expense | $52.2M | +16.2% | +30.1% |
| Operating Income | $45.5M | -2.0% | +134.3% |
| Pre-tax Income | $43.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $221.5M | -41.3% | -33.4% |
| Accounts Receivable | $378.6M | +3.1% | +34.2% |
| Inventory | $180.9M | +1.6% | -7.6% |
| Current Assets | $866.5M | -16.6% | -4.0% |
| Total Assets | $1.61B | +4.5% | +3.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $58.1M | — | — |
| Capital Expenditures | $14.5M | — | — |
| Investing Cash Flow | -$179.4M | — | — |
| Financing Cash Flow | -$25.5M | — | — |
| Free Cash Flow | $43.6M | — | — |
| -23.6% |
| +131.6% |
| Income Tax | $9.9M | -27.0% | +158.2% |
| Net Income | $33.5M | -22.6% | +123.7% |
| EPS (Basic) | $0.12 | -36.8% | +111.8% |
| EPS (Diluted) | $0.12 | -36.8% | +111.8% |
| $458.5M |
| -2.1% |
| +22.3% |
| Long-term Debt | $658.4M | +0.1% | +1.6% |
| Total Liabilities | $1.21B | +2.5% | +9.1% |
| Stockholders' Equity | -$46.7M | +34.1% | -172.4% |